ARS Pharmaceuticals, Inc.

Q2 2026 13F Holders

Symbol
SPRY
CUSIP
82835W108
Type
Equity
Class
COM
Num filings
219
Total reported value, excl. options
$773 M
Manager Report Date Value ($000) Shares Option Type